Laidlaw Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-509	Closed	-$447K	–	226
2023 Q4	$447K	Buy	509 +132	+35%	+$109K	0.16%	140
2023 Q3	$310K	Sell	377 -56	-13%	-$44K	0.1%	196
2023 Q2	$311K	Sell	433 -39	-8%	-$30.1K	0.06%	261
2023 Q1	$388K	Hold	472	–	–	0.08%	230
2022 Q4	$341K	Sell	472 -2	-0.4%	-$1.48K	0.07%	250
2022 Q3	$327K	Buy	474 +34	+8%	+$21.4K	0.08%	225
2022 Q2	$260K	Hold	440	–	–	0.05%	296
2022 Q1	$307K	Sell	440 -2	-0.5%	-$1.26K	0.05%	297
2021 Q4	$279K	Buy	442 +5	+1%	+$3.07K	0.04%	321
2021 Q3	$264K	Sell	437 -3	-0.7%	-$1.86K	0.07%	199
2021 Q2	$246K	Buy	+440	New	+$223K	0.06%	218
2021 Q1	–	Sell	-431	Closed	-$208K	–	327
2020 Q4	$208K	Buy	431 +9	+2%	+$4.86K	0.04%	331
2020 Q3	$236K	Buy	+422	New	+$256K	0.1%	180